Young Alethia bought PTCT
February 15, 2024 · Form 4 insider transaction
Young Alethia bought 4,000 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
InsiderYoung Alethia
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 15, 2024
Filing dateFebruary 16, 2024
Shares owned after13,067
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025.